Loading...
Loading...
India's irbesartan imports from GERMANY total $301 across 1 shipments from 1 foreign suppliers. PRIVAPOSERVICES GMBH leads with $301 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include AGIO PHARMACEUTICALS LIMITED. This corridor reflects India's pharmaceutical import demand for irbesartan โ a concentrated sourcing relationship with select suppliers from GERMANY.

PRIVAPOSERVICES GMBH is the leading Irbesartan supplier from GERMANY to India, with import value of $301 across 1 shipments. The top 5 suppliers โ PRIVAPOSERVICES GMBH โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PRIVAPOSERVICES GMBH | $301 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AGIO PHARMACEUTICALS LIMITED | $301 | 1 | 100.0% |
GERMANY โ India trade corridor intelligence
The Germany to India trade corridor for pharmaceutical imports is currently stable. Major ports like Jawaharlal Nehru Port Trust (JNPT), Chennai, and Mundra are operating efficiently, with minimal congestion. Freight rates have remained consistent over the past year, and the exchange rate between the Euro and the Indian Rupee has shown moderate fluctuations, not significantly impacting trade dynamics.
The Indian government's Production Linked Incentive (PLI) scheme aims to boost domestic manufacturing, potentially reducing reliance on imported finished formulations. However, the PLI scheme primarily targets domestic production and may not directly affect imports of specialized formulations like Irbesartan. Import substitution policies are being evaluated, but their impact on finished formulation imports from Germany is currently limited.
India and Germany maintain strong trade relations, with ongoing discussions to enhance pharmaceutical trade. Negotiations for Free Trade Agreements (FTAs) are in progress, which may lead to preferential trade terms in the future. Mutual recognition of Good Manufacturing Practices (GMP) is being considered to facilitate smoother trade and ensure product quality. These initiatives aim to strengthen bilateral trade and address regulatory challenges.
The landed cost of importing finished Irbesartan formulations from Germany to India includes the following components:
The total landed cost per unit is calculated by summing these components, which can vary based on the specific terms of the transaction and prevailing rates.
CDSCO registration, import licensing, and quality testing requirements
Importing finished pharmaceutical formulations containing Irbesartan into India requires compliance with the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The Central Drugs Standard Control Organization (CDSCO) mandates that both the drug and the manufacturing site be registered. For new drugs, approval under Rule 122E is necessary before importation. Applications for registration and import licenses must be submitted to the Drugs Controller General (India) at CDSCO. The registration process involves submitting detailed product information, manufacturing details, and quality control data. The timeline for import drug registration varies but typically ranges from several months to over a year, depending on the complexity of the product and the completeness of the application. For formulations under HS Code 30049079, specific requirements include comprehensive stability data, quality control measures, and compliance with Indian Pharmacopoeia standards.
Imported finished pharmaceutical formulations containing Irbesartan must undergo quality testing at CDSCO-approved laboratories. Batch-wise testing is mandatory, with each batch requiring a Certificate of Analysis (CoA) confirming compliance with Indian Pharmacopoeia standards. Stability data, particularly for ICH Zone IV conditions, must be provided to demonstrate the product's shelf-life under Indian climatic conditions. Port inspection by customs drug inspectors is conducted to verify compliance with regulatory standards. If a batch fails quality testing, it may be subject to rejection, destruction, or re-export, depending on the severity of the non-compliance.
Between 2024 and 2026, the CDSCO has implemented stricter regulations for the importation of pharmaceutical products to enhance drug safety and efficacy. The introduction of the Production Linked Incentive (PLI) scheme has incentivized domestic manufacturing, potentially impacting the volume of finished formulation imports. Bilateral agreements between India and Germany have facilitated smoother trade relations, including mutual recognition of Good Manufacturing Practices (GMP), which may streamline the import process for German manufacturers.
Market demand, customs duty structure, and competitive landscape ยท Import duty: 10%
India imports finished Irbesartan formulations to meet the demand for branded and patented products not manufactured domestically. Specific dosage forms, such as extended-release tablets, may not be produced locally, necessitating imports. Despite a robust domestic pharmaceutical industry, certain specialized formulations are sourced from abroad to fulfill market needs. The market size for Irbesartan formulations in India is substantial, with a growing patient population requiring antihypertensive treatments.
The Basic Customs Duty (BCD) for finished pharmaceutical formulations under HS Code 30049079 is 10%. An additional Social Welfare Surcharge (SWS) of 10% on BCD is applicable. Integrated Goods and Services Tax (IGST) is levied as per prevailing rates, which vary based on the product classification and applicable notifications. There are no specific exemptions or concessional duties for products originating from Germany under this HS Code. The total landed duty percentage combines BCD, SWS, and IGST, impacting the final cost of imported goods.
India sources finished Irbesartan formulations from Germany due to the country's strong pharmaceutical manufacturing capabilities, adherence to international quality standards, and the availability of specialized dosage forms not produced domestically. Germany's share in India's Irbesartan import market is significant, reflecting its competitive advantage in quality and innovation. Other suppliers, such as China and the United States, also participate in this market, but Germany's reputation for high-quality pharmaceutical products positions it favorably.
Import rationale, competitive comparison, supply chain risk, and procurement strategy
India imports finished Irbesartan formulations from Germany due to the availability of patented formulations, specialized dosage forms, and technology-licensed products that are not manufactured domestically. Germany's advanced pharmaceutical manufacturing capabilities and adherence to international quality standards make it a preferred source for these formulations.
Compared to other origins like China, the European Union, and the United States, Germany offers advantages in terms of product quality, regulatory compliance, and reliability. While other countries may offer competitive pricing, Germany's reputation for high-quality pharmaceutical products and adherence to stringent regulatory standards provide a unique advantage in the Indian market.
Potential risks for Indian importers include single-source dependency, currency fluctuations, regulatory changes, quality incidents, and shipping disruptions. Past shortages have occurred due to quality issues and regulatory recalls, emphasizing the need for robust risk management strategies.
Import license checklist, document requirements, quality testing, and compliance
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Irbesartan suppliers from GERMANY to India include PRIVAPOSERVICES GMBH. The leading supplier is PRIVAPOSERVICES GMBH with import value of $301 USD across 1 shipments. India imported Irbesartan worth $301 USD from GERMANY in total across 1 shipments.
India imported Irbesartan worth $301 USD from GERMANY across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Irbesartan sourced from GERMANY include AGIO PHARMACEUTICALS LIMITED. The largest buyer is AGIO PHARMACEUTICALS LIMITED with $301 in imports across 1 shipments.
The total value of Irbesartan imports from GERMANY to India is $301 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists